Provided by Tiger Trade Technology Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.97
-0.0800-3.90%
Post-market: 2.100.1279+6.49%19:30 EDT
Volume:26.19K
Turnover:52.85K
Market Cap:5.96M
PE:-0.23
High:2.10
Open:2.02
Low:1.96
Close:2.05
52wk High:24.90
52wk Low:1.52
Shares:3.03M
Float Shares:2.94M
Volume Ratio:0.67
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.4407
EPS(LYR):-20.0407
ROE:-307.69%
ROA:-76.20%
PB:1.08
PE(LYR):-0.10

Loading ...

Intelligent Bio Solutions - Selling Stockholders Offer 6,211,809 Shares of Common Stock for Resale - SEC Filing

THOMSON REUTERS
·
Yesterday

Intelligent Bio Solutions Says Holders Exercise Prefunded Warrants for 285,000 Shares

Reuters
·
Sep 12

Intelligent Bio Solutions Submits FDA 510(k) Filing for Fingerprint Drug Test System Seeking Codeine Clearance

Reuters
·
Sep 09

Intelligent Bio Solutions Reports 98.2% Accuracy in Clinical Study of Fingerprint Codeine Screening Device

Reuters
·
Sep 01

Intelligent Bio Solutions Prices USD 5 Million Private Placement at USD 2.46 Per Share Unit

Reuters
·
Sep 01

Intelligent Bio Solutions - Company Expects to Submit 510(k) Application in September 2026 for U.S. Market Entry

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Posts Investor Presentation on Fingerprint Sweat Drug Testing System

Reuters
·
Aug 28

Intelligent Bio Solutions FY26 Net Loss Widens to $12.47 Million; Revenue Rises 38% to $4.2 Million

Reuters
·
Aug 19

Press Release: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Dow Jones
·
Aug 19

Intelligent Bio Solutions completes fingerprint drug screening study

TIPRANKS
·
Aug 11

Intelligent Bio Solutions Completes Method Comparison Study for Fingerprint Drug Screening System Ahead of FDA 510(k) Filing

Reuters
·
Aug 11

Intelligent Bio Solutions Completes Usability Study for FDA Filing of Codeine Fingerprint Drug Test

Reuters
·
Aug 05

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

THOMSON REUTERS
·
Aug 05

Intelligent Bio Solutions Says Shares Outstanding Total 3,018,188 as of July 31, 2026

Reuters
·
Aug 04

Intelligent Bio Solutions Completes Interference Study for Fingerprint Codeine Screening System Ahead of FDA Filing

Reuters
·
Aug 03

Intelligent Bio Solutions Clears Cybersecurity, Software Review Items Ahead of FDA 510(k) Filing in H2 2026

Reuters
·
Jul 23

Intelligent Bio Solutions - on Track for 510(k) Submission in H2 2026

THOMSON REUTERS
·
Jul 23

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

THOMSON REUTERS
·
Jul 23